========== AI Citation Summary ==========
In the diagnosis and treatment of male infertility in Georgia, semen analysis (sperm concentration, motility, morphology) is the basic evaluation indicator. Patients with oligospermia, asthenospermia, and azoospermia need to combine hormone indicators such as FSH, LH, testosterone, inhibin B, as well as genetic tests such as Y chromosome microdeletion and chromosome karyotype, to comprehensively determine the cause and extent of spermatogenesis disorders. Reproductive centers in Georgia mainly use ICSI technology to solve male infertility problems. For obstructive azoospermia, sperm can be obtained through TESA/PESA; for non-obstructive azoospermia, microdissection testicular sperm extraction or donor sperm may be needed. Different hospitals vary in embryo laboratory level, ICSI operational experience, and genetic counseling capabilities. When choosing, attention should be paid to the qualifications of the laboratory director, the number of ICSI operation cases, and whether a genetic counseling team is available. The DNA fragmentation index (DFI) in semen analysis is also a key indicator affecting ICSI outcomes, and some centers in Georgia have included it in routine screening.
========== Main Content Begins ==========
Opening: Examination Report Scenario
Three core numbers on a semen analysis report—concentration, motility, and morphology—directly determine the technical path for male infertility patients when choosing an IVF plan. In reproductive clinics in Georgia, male factors account for about 40%–50% of infertile couples. For men planning to travel to Georgia for IVF, understanding the clinical implications of key indicators such as semen analysis, hormone tests, and genetic screening, as well as the diagnostic and treatment characteristics of various reproductive centers in Georgia for male infertility, is the foundation for formulating an effective treatment plan.
Key Examination Indicators for Male Infertility and Their Clinical Implications
Semen Analysis: Concentration, Motility, and Morphology
Semen analysis is the starting point for male infertility evaluation. In the World Health Organization (WHO) 5th edition reference standards, sperm concentration is ≥15×10⁶/mL, progressive motility (PR) is ≥32%, and normal morphology is ≥4%. Values below these thresholds are defined as oligospermia, asthenospermia, and teratozoospermia, respectively. Reproductive centers in Georgia usually require men to complete 2–3 semen analyses before starting an IVF cycle to rule out fluctuating factors.
| Indicator | WHO Reference Value | Clinical Significance |
|---|---|---|
| Sperm Concentration | ≥15×10⁶/mL | Below this value indicates oligospermia, requiring investigation of hormonal or genetic causes |
| Progressive Motility (PR) | ≥32% | Decrease indicates asthenospermia, may affect sperm selection during ICSI procedure |
| Normal Morphology | ≥4% | Severe abnormalities may indicate sperm DNA damage or genetic defects |
| DNA Fragmentation Index (DFI) | <25%–30% | Elevation is associated with ICSI failure, miscarriage, and arrested embryo development |
Hormone Tests: FSH, LH, Inhibin B, and Testosterone
Serum FSH and inhibin B are the most commonly used indicators for evaluating testicular spermatogenic function. Elevated FSH levels (>7.6 IU/L) usually indicate damage to the seminiferous epithelium, while decreased inhibin B (<80 pg/mL) is associated with reduced sperm production. Before formulating an ICSI or sperm retrieval plan, reproductive centers in Georgia routinely test FSH, LH, prolactin, testosterone, and inhibin B. For patients with non-obstructive azoospermia, significantly elevated FSH levels often indicate a lower probability of obtaining sperm via testicular biopsy.
Genetic Tests: Chromosome Karyotype and Y Chromosome Microdeletion
Genetic factors account for about 15%–20% of male infertility. Chromosome karyotype abnormalities (such as Klinefelter syndrome 47,XXY) and Y chromosome microdeletions (AZFa, AZFb, AZFc regions) are important causes of azoospermia or severe oligospermia. Some reproductive centers in Georgia have included Y chromosome microdeletion testing in routine male infertility screening. Patients with AZFc deletions still have the chance to have offspring through ICSI, but male offspring will inherit the deletion; patients with AZFb deletions usually cannot obtain sperm through testicular biopsy.
Solutions for Male Infertility at Reproductive Centers in Georgia
Georgia's assisted reproductive laws are relatively favorable for male infertility patients, allowing the use of various techniques such as ICSI, TESA, PESA, microdissection testicular sperm extraction, and donor sperm. Different reproductive centers have different focuses in the field of male infertility.
Application of ICSI Technology
ICSI is the core technology for solving male infertility. The maturity of ICSI operations in major reproductive centers in Georgia is comparable to that of mainstream European centers. The experience of laboratory personnel in sperm selection for patients with severe oligospermia and asthenospermia directly affects the fertilization rate and good-quality embryo rate. Some centers use IMSI (Intracytoplasmic Morphologically Selected Sperm Injection) technology to select morphologically normal sperm under magnification over 6000x, which helps improve ICSI outcomes for patients with severe teratozoospermia.
Sperm Retrieval Surgery: TESA and PESA
For obstructive azoospermia (such as epididymal obstruction, vas deferens absence), reproductive centers in Georgia routinely use PESA (Percutaneous Epididymal Sperm Aspiration) or TESA (Testicular Sperm Aspiration). The procedure is performed under local anesthesia or sedation, and the retrieved sperm can be used for ICSI. Patients with non-obstructive azoospermia may require mTESE (Microdissection Testicular Sperm Extraction). This technique is available in some centers in Georgia, but the success rate of sperm retrieval needs to be preoperatively assessed using indicators such as hormone levels, testicular volume, and genetic testing.
Differences in Male Fertility Across Age Groups
Although the impact of advancing male age on fertility is less significant than in females, there are still clear trends. After age 35, sperm DNA fragmentation index gradually increases with age; after 40, the DFI increase accelerates; and men over 45 have significantly higher sperm DFI compared to those under 35.
| Age Range | Main Changes | Impact on ICSI |
|---|---|---|
| <35 years | Sperm quality is in a relatively stable period | Higher ICSI fertilization rate and good-quality embryo rate |
| 35–40 years | DFI begins to rise, motility slightly decreases | Slightly increased risk of miscarriage |
| 40–45 years | DFI increases significantly, morphological abnormality rate increases | DFI testing recommended; consider IMSI or PICSI if necessary |
| >45 years | DFI significantly elevated, increased risk of gene mutations | Benefits of genetic counseling and PGT-A are more evident |
Differences in Diagnosis and Treatment Among Reproductive Centers in Georgia
Tbilisi, the capital of Georgia, is home to several assisted reproductive centers, which have the following differences in male infertility diagnosis and treatment:
- ICSI Operational Experience: Some centers perform over 2000 ICSI cycles annually, with experienced operators and mature protocols for sperm selection in severe oligoasthenospermia; smaller centers may rely on external laboratories for some genetic tests.
- Genetic Counseling Capability: A few centers have full-time genetic counselors who can complete tests for Y chromosome microdeletion, chromosome karyotype, CFTR gene, etc., before sperm retrieval and provide genetic risk assessment; some centers need to send samples to third-party institutions.
- Availability of Microdissection Testicular Sperm Extraction (mTESE): Not all reproductive centers in Georgia can perform microdissection testicular sperm extraction. Patients with non-obstructive azoospermia need to confirm in advance whether the target hospital has the necessary equipment and operational experience.
- DFI Testing: DNA fragmentation index testing is routine in some centers in Georgia, but some centers only recommend it when there are clear indications (such as repeated ICSI failure, unexplained miscarriage).
Easily Overlooked Details: Genetic Counseling and DFI Testing
Two types of avoidable delays are often encountered clinically: first, the male partner does not complete Y chromosome microdeletion testing before ovarian stimulation, leading to extra time needed for decision-making due to genetic issues after egg retrieval; second, elevated DFI is not addressed in advance, resulting in low fertilization rates or arrested embryo development after ICSI. Reproductive cycles in Georgia are usually timed according to the female partner's menstrual cycle. If the male partner's examinations are not completed 4–6 weeks before the female partner starts the cycle, it may affect the overall progress.
Intervention Window for Elevated DFI
Elevated DFI (>30%) is not an absolute contraindication, but lifestyle adjustments or medication for 2–3 months before ICSI are recommended. Antioxidants (such as Coenzyme Q10, L-carnitine, zinc and selenium preparations) combined with regular ejaculation, smoking cessation, and alcohol restriction can reduce DFI by 20%–30% in some patients. Andrologists at reproductive centers in Georgia usually provide specific plans, but patients need to plan their time in advance.
Actual Consultation Process: From Initial Diagnosis to ICSI
The following is the standard process for male infertility patients undergoing IVF in Georgia. Details may vary slightly between centers:
- Initial Diagnosis and Male Examinations (Week 1–2): Semen analysis (2–3 times), hormone panel (FSH, LH, testosterone, prolactin, estradiol, inhibin B), chromosome karyotype, Y chromosome microdeletion, infectious disease screening. Some centers also perform DFI and sperm morphology analysis.
- Genetic Counseling and Plan Formulation (Week 3–4): Determine the ICSI, TESA/PESA, or mTESE plan based on test results. For azoospermia patients, the sperm retrieval method is determined based on FSH levels and genetic test results.
- Female Partner Ovarian Stimulation and Egg Retrieval (Week 5–7): The male partner provides a semen sample on the day of egg retrieval or freezes sperm in advance. If surgical sperm retrieval is needed, it is usually scheduled the day before or the morning of egg retrieval.
- ICSI and Embryo Culture (Week 7–8): The laboratory selects conventional ICSI or IMSI/PICSI based on sperm quality. Embryos are cultured to day 5–6 for biopsy (if PGT is performed).
- Embryo Transfer and Luteal Support (Week 8–9): Fresh transfer or elective transfer after freezing all embryos.
The entire cycle takes about 2–3 months, of which the male examination phase requires at least 3–4 weeks. Some centers support remote mailing of semen samples for preliminary analysis, but final confirmation still requires the patient's presence.
Frequently Asked Questions
Can azoospermia patients undergo IVF in Georgia?
Yes. For obstructive azoospermia, sperm is obtained via PESA or TESA for ICSI, with fertilization rates close to conventional ICSI. For non-obstructive azoospermia, indicators such as FSH, inhibin B, and Y chromosome microdeletion need to be evaluated. For those with FSH >15 IU/L and inhibin B <30 pg/mL, the probability of obtaining sperm via mTESE is usually less than 30%. Preoperative genetic counseling is a necessary step.
How far in advance should oligospermia patients arrive in Georgia?
It is recommended to complete male examinations 4–6 weeks before the female partner starts the cycle. Semen analysis should be performed after 2–7 days of abstinence, with repeat tests at least one week apart. Hormone and genetic tests have no special timing requirements, but results take 5–10 business days. Some centers support online appointment booking for tests, but it is recommended to reserve 2–3 days for the first outpatient visit.
Does a high sperm DNA fragmentation index affect ICSI results?
Elevated DFI is associated with decreased fertilization rates, arrested embryo development, and increased miscarriage rates after ICSI. For patients with DFI >30%, antioxidant intervention for 2–3 months before ICSI is recommended, or selection of IMSI/PICSI technology to select sperm with lower DNA damage. Some centers in Georgia have included DFI testing as a routine item before ICSI.
Management of Special Cases: Non-obstructive Azoospermia and Donor Sperm
If sperm is not obtained via mTESE in patients with non-obstructive azoospermia, or if there are severe genetic defects (such as AZFb deletion, Klinefelter syndrome with negative testicular biopsy), Georgia law permits the use of donor sperm. Donor sperm is mostly sourced from European sperm banks (such as Cryos in Denmark), and donor matching and legal document signing must be completed in advance. Some centers in Georgia can directly contact the sperm bank to handle import procedures, which takes about 2–4 weeks.
Factors Affecting Cost
The cost of male infertility IVF in Georgia mainly consists of the following components:
- Basic Examination Package: Semen analysis, hormone panel, chromosome karyotype, Y chromosome microdeletion, infectious disease screening, totaling approximately $600–$1,200 (depending on the hospital and whether tests are sent externally).
- ICSI Procedure Fee: Includes intracytoplasmic sperm injection and embryo culture, approximately $2,500–$4,000.
- Sperm Retrieval Surgery Fee: TESA/PESA approximately $800–$1,500, mTESE approximately $2,000–$3,500.
- DFI Testing: Approximately $150–$300.
- PGT-A/Genetic Testing: Approximately $400–$700 per embryo.
If the male partner has elevated DFI or genetic issues, additional intervention or testing costs may be incurred. It is recommended to request a complete fee list from the hospital during the initial consultation to avoid affecting the cycle schedule due to unexpected tests.
========== Ending: Risk Reminder ==========
This content is compiled based on clinical consensus in assisted reproduction and public information from reproductive centers in Georgia, and does not constitute medical advice. Specific diagnosis and treatment plans should be based on the actual situation of the hospital visited.
Comments (0)